FDA Nutrition Label Proposal, Osteoporosis Screening, and U.S. Obesity Decline
Morning Medical with Dr. Chow
A daily update covering the latest medical & health news from around the world using artificial intelligence. Doctor Chi-Ming Chow is a family physician, general internist, and cardiologist. He is also a Professor of Medicine at the University of Toronto.
Chi-Ming Chow
PodcastAI
PodcastAI

FDA Nutrition Label Proposal, Osteoporosis Screening, and U.S. Obesity Decline

E149 • Jan 15, 2025 • 22 mins

In this episode, Dr. Chi-Ming Chow covers the FDA's proposed 'Nutrition Info' label for chronic disease prevention, inviting public feedback. He updates osteoporosis screening guidelines, focusing on diverse populations. The health risks of heavy metals in protein powders are discussed, along with consumer safety tips. Dr. Chow shares news of Catherine, Princess of Wales, in cancer remission. He reviews U.S. News & World Report's healthcare rankings, examining methodology and median salaries. The episode concludes with a discussion on the decline in U.S. obesity rates and the impact of GLP-1 medications.

Key Points

  • The FDA has proposed a new rule requiring prominent 'Nutrition Info' labels on food packages to inform consumers about high, medium, or low levels of sodium, saturated fats, and added sugars.
  • A recent report from the Clean Label Project has raised concerns about heavy metals like lead and cadmium in protein powders, especially in plant-based and chocolate-flavored varieties.
  • Obesity rates in the United States have decreased for the first time in over a decade, with GLP-1 medications like Ozempic and Wegovy being credited as significant contributors to this decline.
Listen on Apple PodcastsListen on Spotify
- / -